Recent Coverage


January 11, 2017

Cantech Letter
RepliCel CEO Lee Buckler talks to Cantech Letter
View Article by Nick Waddell on Cantech Letter click here (1/11/2017) Read full article

December 7, 2016

The Jake Brown Show
Episode 10: SNY’s Taylor Rooks, Stylist Megan Wilson, Replicel’s Lee Buckler Released Dec 07, 2016 View for free on iTunes: click here JB opens... Read full article

November 28, 2016

Total Tutor with Neil Haley
The Total Tutor Neil Haley will interview Lee Buckler of Replicel. Click here to view: Read full article

March 23, 2016

The Asahi Shimbun
Shiseido to trial baldness ‘cure’ for planned commercial launch in 2018
Find full article here online, at The Asahi Shimbun. Read full article

March 3, 2016

The Life Sciences Report: Streetwise Reports
Embrace Low-Cap Biotech for High Gains: Eden Rahim of Next Edge Capital
Source: George S. Mack of The Life Sciences Report  (3/2/16) View the full article as is appears here, on The Life Sciences Report. Eden Rahim... Read full article

November 16, 2015

The Globe and Mail
How Japan ‘Changed the System’
Japan’s Bold Steps By: Iain Marlow ASUKE, JAPAN The Globe and Mail Last updated: Saturday, Nov. 14, 2015 3:41PM EST People over the age... Read full article

October 27, 2015

Financial Post
Canada’s emerging cell therapy biotech industry
Canadian companies driving global breakthroughs in regenerative medicine By Kathryn Boothby To read this article on the Financial Post website, click here. Rapid advances in... Read full article

September 16, 2015

Japan’s regulatory gamble and what it means for the Industry
Navigating the Global Regulatory Landscape Written by: Lee Buckler & Colin Lee Novick The Follower Takes the Lead:  How Japan’s trifecta of economic policy,... Read full article

September 9, 2015

The Life Sciences Report
Alan Leong of BioWatch Looks Beyond the Buzz for Solid Early-Stage Plays RP, CAPR, CTRV, CPXX, SRNE, SNSS
To read the full article as it appears on The Life Sciences Report, click here. Source: Gail Dutton of The Life Sciences Report  (9/9/15) CAR... Read full article

August 12, 2015

The Life Science Report
Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital’s Eden Rahim
To read the full article as it appears on The Life Science Report, please click here. Volatility is the nature of the biotech beast,... Read full article